Delivery Order SPE2DB20D7059-SPE2DB25FQMN3
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Methylene Blue 50 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,338.95 and an ultimate completion date of August 14, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for Methylene Blue 50 mg/10 mL vials with a ceiling value of $1,034.34. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The contract is set to complete by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,124.90 to AmerisourceBergen Drug Corp for the supply of Methylene Blue 1% in 10 mL vials. This contract was competitively awarded without any set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 15, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a $1,089.31 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Methylene Blue 1% in 10mL vials. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis, reflecting the contractor's established capability to meet federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,274.45, is for 4563920301 - METHYLENE BLUE 50 MG/10ML VIAL 10ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,253.68 firm fixed-price delivery order is for the supply of 4566243396 - Methylene Blue 50 mg/10 mL vial, 10 mL. The award has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- The Defense Logistics Agency awarded a $2,847.08 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Methylergonovine 0.2 mg tablets (28-count) with a firm fixed price ceiling value of $1,547.44. The contract was competitively awarded with no set-aside designation and is scheduled for ultimate completion on August 22, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Methylergonovine 0.2 mg/mL injection vials, with a firm fixed price of $1,355.56 and an ultimate completion date of September 16, 2025. This non-competitive delivery order represents a single-transaction pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,847.23 to AmerisourceBergen Drug Corp for Isosulfan Blue 1% Vial 5ML, a contrast agent used in medical diagnostic and surgical procedures. The contract employs firm fixed price terms with a delivery completion date of July 23, 2025, one day after the award date of July 22, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken,...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQMN3Delivery Order
The Defense Logistics Agency awarded a $13,994.73 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Methylene Blue 1% vials (10mL) with an ultimate completion date of August 5, 2025. This contract utilizes firm fixed pricing and was competitively awarded without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive DLA prime contract vehicle. The company supplies a broad range of pharmaceuticals and medical supplies to support military healthcare systems and Defense Health Agency operations globally. This specific delivery order for methylene blue—a pharmaceutical commonly used in medical and diagnostic applications—exemplifies the routine procurement activity conducted under the parent IDC framework, which enables flexible sourcing of pharmaceutical products across multiple therapeutic domains to meet military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 8/4/25 |